M Cunningham, PhD

Co-Founder and Chief Scientific Officer Moleculera Labs

Sue Swedo,MD

Chief of the Pediatrics and Developmental Neuroscience Branch (PDN) in the Intramural Research Program (IRP) of the National Institute of Mental Health NIMH

J. F. Leckman, MD

Neison Harris Professor of Child Psychiatry, Psychiatry, Psychology and Pediatrics,

Yale University  

James F. Leckman, M.D. is the Neison Harris Professor of Child Psychiatry, Psychiatry, Psychology and Pediatrics at Yale. He served as the Director of Research for the Yale Child Study Center from 1983 to 2010. Dr. Leckman is a well known child psychiatrist and patient-oriented clinical investigator. His peers have regularly selected him as one of the Best Doctors in America. Dr. Leckman is the author or co-author of over 300 original articles published in peer-reviewed journals, seven books, and 120 book chapters. In 2002, he was identified by American Society for Information, Science and Technology as a “Highly Cited Researcher” - one of the world's most cited authors in Psychology and Psychiatry – in the top half of the top one percent of all publishing researchers.

 

In 1999, he edited with Dr. Donald J. Cohen, Tourette's Syndrome: Tics, Obsessions, Compulsions - Developmental Psychopathology and Clinical Care, published by John Wiley&Sons. Given its success, this volume was re-issued in paper back in the fall of 2001. More recently, Dr. Leckman edited (along with Andres Martin, Lawrence Scahill and Dennis Charney) a 56-chapter volume, entitled, Pediatric Psychopharmacology: Principles and Practice published in October of 2002 by Oxford University Press. In November 2002, an invited review article on Tourette’s syndrome appeared in the prestigious medical journal The Lancet. Other recent editorials have appeared in the Journal of Child Psychology and Psychiatry (2011), Journal of the American Academy of Child and Adolescent Psychiatry (2011), Neuropsychopharmacology (2011), and the British Medical Journal (2012).

Dr. Susan Swedo is Chief of the Pediatrics and Developmental Neuroscience Branch (PDN) in the Intramural Research Program (IRP) of the National Institute of Mental Health NIMH). She received her M.D. from Southern Illinois University School of Medicine and completed a pediatrics residency at Children’s Memorial Hospital in Chicago.  Following her training, Dr. Swedo served as Chief of Adolescent Medicine for Northwestern University until 1986, when she joined Dr. Judith Rapoport’s laboratory at the National Institute of Mental Health (NIMH). Dr. Swedo received tenure in the NIMH Intramural Research Program in 1992 and became Head of the NIMH Section on Behavioral Pediatrics in 1994. She served as Acting Director of the NIMH-IRP from 1995 – 1998 and NIMH Associate Director for Child and Adolescent Research from 2003 – 2007. She was the founding Director of the NIMH Division of Pediatric Translational Research and Treatment Development and served until March 2006, when she returned to the NIMH IRP and assembled a multi-disciplinary team to conduct clinical research on the causes and treatment of autism spectrum disorders and obsessive-compulsive disorder (OCD). Dr. Swedo and her colleagues were the first to identify a post-infectious subtype of OCD, which is known as PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections). This line of research has resulted in several novel treatment and prevention strategies for childhood-onset OCD, including use of immunomodulatory therapies to treat acutely ill children and antibiotics prophylaxis to forestall future neuropsychiatric symptom exacerbations.

 

 

Dr. Cunningham is  Co-founder and Chief Scientific Officer of Moleculera Labs. She is the George Lynn Cross Research Professor and the Presbyterian Health Foundation Presidential Professor and Microbiology and Immunology Director, Immunology Training Program University of Oklahoma Health Sciences Center. Dr. Cunningham’s laboratory has studied molecular mimicry, autoimmunity and infection related to inflammatory heart disease for the past 30 years. She has pioneered the development of human mAbs in understanding the pathogenesis of human diseases. Currently her laboratory is focused on translational studies of human diseases, to improve their diagnosis and treatment and determine how infections play a role in autoimmune diseases of the heart and brain. Dr. Cunningham is the director of an NIAID supported Immunology Training Program at the University of Oklahoma for the past 10 years. She has been the recipient of NHLBI Career Development and MERIT Awards and has been funded by NIH for the past 25 years. She is author of over 100 publications in peer-reviewed journals and speaks internationally on the findings of her research.

 

Dr. Cunningham’s laboratory studies the role of autoimmunity and infection in the pathogenesis of movement and behavioral disorders associated with streptococci, including Sydenham chorea, the neurologic manifestation of rheumatic fever, and pediatric autoimmune neurologic disorder associated with streptococci (PANDAS). Her laboratory identified antibody mediated neuronal cell signaling as the potential basis for choreic movement disorders. Other related movement and neuropsychiatric disorders such as obsessive-compulsive disorder, Tourette’s Syndrome and Tics are under investigation to determine the presence and role of autoantibodies which may signal in the brain for these diseases.  

 

Copyright © 2015 PANDAS Como - All Rights Reserved | PANDASCOMO.com

Copyright © 2015 PANDAS Como - All Rights Reserved | PANDASCOMO.com

Copyright © 2015 PANDAS Como - All Rights Reserved | PANDASCOMO.com

Copyright © 2015 PANDAS Como - All Rights Reserved | PANDASCOMO.com

Copyright © 2015 PANDAS Como - All Rights Reserved | PANDASCOMO.com

Copyright © 2015 PANDAS Como - All Rights Reserved | PANDASCOMO.com

Copyright © 2015 PANDAS Como - All Rights Reserved | PANDASCOMO.com

Copyright © 2016 PANDAS Como - All Rights Reserved | PANDASCOMO.com

SPEAKERS

SPEAKERS

 

M. Elizabeth Latimer, MD received her medical degree from Tufts University School of Medicine in Boston Massachusetts. She completed her residencies in Pediatrics and Neurology at Walter Reed Army Medical Center in Washington, DC, with special certification in Child Neurology. She served as chief of the Child Neurology Division at Georgetown University Hospital in Washington, DC for five years, prior to practicing at Fairfax Hospital in Virginia.

 

In 2000, Dr. Latimer opened her current practice of Child and Adolescent Neurology in Bethesda, MD, where she provided treatment for autism, ADHD, migraines, and other neurological conditions. In addition to her general neurology and headache practice, Dr. Latimer specializes in caring for PANDAS patients, and cerebral palsy patients who require spasticity management.

 

Throughout her years of working in the field of Child and Adolescent Neurology, Dr. Latimer has been involved with several health and non-profit organizations. Dr. Latimer has also had the honor of presenting at several events for the Child Neurology Society, the American Academy of Neurology, and has appeared in national news media as an expert in Child and Adolescent Neurology topics. Recently she was invited as a speaker for NIH, Pandas Working Group, International OCD foundation, New England Pandas Association, and Pandas d’italia. For her commitment to her patients, and excellent service, Dr. Latimer has received recognition such as being named as a Top Doctor by the Washingtonian Magazine from 1994-2012, and also received the Compassionate Doctor Award.

 

M. E. Latimer, MD

Prof. Child Neurology

Georgetown University,

Latimer Neurology Center

Washington, DC USA  

Visit  Select Talks

Video Conference Replay            

Videos European PANDAS 2015            

Sue E Swedo,MD

Chief of the Pediatrics and Developmental Neuroscience Branch (PDN) in the Intramural Research Program (IRP) of the National Institute of Mental Health NIMH

Speaker Biographies

M W Cunningham, PhD

Co-Founder and Chief Scientific Officer Moleculera Labs

J. F. Leckman, MD

Neison Harris Professor of Child Psychiatry, Psychiatry, Psychology and Pediatrics,

Yale University  

M. E. Latimer, MD

Prof. Child Neurology

Georgetown University,

Latimer Neurology Center, Washington, DC USA  

Diana Pohlman, is the Founder and Executive Director of PANDAS Network.org (est. 2009),,a national patient advocacy nonprofit.  As a parent desperate for medical treatment she relied on Dr. Susan Swedo's "new" NIMH research to successfully heal her young children. Ms.  Pohlman has  worked continuously to bring attention to children and families afflicted with this illness..  She has talked to  hundreds of families with PANDAS-PANS and is a spokesperson and advocate for the early identification and  treatment of children with this acute neuropsychiatric illness associated with infection.   She is proud that together with the NIMH partnership currently 200+ practitioners  treat PANDAS-PANS.  She has promoted continued collaboration with parents, researchers and practitioners through annual conferences  across the U.S., Italy, and Canada.  These efforts have, in part, encouraged the recent  formation of treatment clinics at Stanford U, Georgetown U., Massachusetts General and U. of Missouri.  

Diana Pohlman

Founder and Executive Director

PANDAS Network.org  

Palo Alto, California

Diana Pohlman

Executive Director PANDAS Network

Palo Alto, CA USA

Thanks to the gracious help of Giuliana Galardini of Pandas Italia, Diana Pohlman of PANDAS Network and Lucia Del Vecchio of Ospedale Manzoni,  the European PANDAS Lake Como Conference 2015, held in Como on Saturday 26 and Sunday 27, September 2015, convened world experts in rheumatology, neurology, psychiatry and immunology to address the latest insights into the diagnosis and treatment protocol for PANDAS.  Explore what select speakers had to say.  

 
X

Password: (For Access contact info@smartlocus.com)

Wrong password. Please contact info@smartlocus.com for password access